Literature DB >> 34519991

The Impact of Bariatric Surgery Versus Non-Surgical Treatment on Blood Pressure: Systematic Review and Meta-Analysis.

Laicheng Wang1, Meihua Lin1, Jianjian Yu1, Zongcheng Fan1, Shunpeng Zhang1, Yunchai Lin1, Xin Chen1, Feng Peng2.   

Abstract

The purpose of this study was to compare bariatric surgery versus non-surgical treatment on blood pressure for patients with obesity. Nineteen RCTs (1353 total patients) were included. In the pooled analyses, bariatric surgery reduces more systolic blood pressure (WMD: - 3.937 mmHg, CI95%: - 6.000 to - 1.875, p < 0.001, I2 = 0%), diastolic blood pressure (WMD: - 2.690 mmHg, CI95%: - 3.994 to - 1.385, P < 0.001, I2 = 0%) and more antihypertensives. In subgroup analyses, patients after Roux-en-Y gastric bypass, with poor control of hypertension (BP > 130/80 mmHg) and diabetes mellitus (HbA1C > 7.0%, FPG > 7.0 mmol/L), elder patients (> 45 years), non-severe obesity (BMI < 40 kg/cm2, body weight < 120 kg), less waist circumference (< 115 cm) tend to decrease more blood pressure. Besides, patients after surgery also lost more weight (p < 0.001), decreased more waist circumference (p < 0.001), fasting plasma glucose (p < 0.001), glycosylated hemoglobin (p < 0.001), triglycerides (p < 0.001), hsCRP (p = 0.001), increased more high-density lipoprotein cholesterol (p < 0.001), and had better remission of metabolic syndrome (p < 0.001). Changes in total cholesterol, low-density lipoprotein cholesterol, renal function, resting heart rate, and 6-min walking test were not significantly different. Therefore, bariatric surgery is more effective than non-surgical treatment in controlling patients' blood pressure.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Bariatric surgery is a more effective way of controlling patients' blood pressure; LAGB has no advantage in blood pressure control compared to non-surgical treatment; RYGB has the most certain efficacy on blood pressure reduction among all surgeries

Mesh:

Substances:

Year:  2021        PMID: 34519991     DOI: 10.1007/s11695-021-05671-9

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   3.479


  39 in total

1.  Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery.

Authors:  Lars Sjöström; Anna-Karin Lindroos; Markku Peltonen; Jarl Torgerson; Claude Bouchard; Björn Carlsson; Sven Dahlgren; Bo Larsson; Kristina Narbro; Carl David Sjöström; Marianne Sullivan; Hans Wedel
Journal:  N Engl J Med       Date:  2004-12-23       Impact factor: 91.245

2.  Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial.

Authors:  Geltrude Mingrone; Simona Panunzi; Andrea De Gaetano; Caterina Guidone; Amerigo Iaconelli; Esmeralda Capristo; Ghassan Chamseddine; Stefan R Bornstein; Francesco Rubino
Journal:  Lancet       Date:  2021-01-23       Impact factor: 79.321

Review 3.  Weight loss and blood pressure control (Pro).

Authors:  David W Harsha; George A Bray
Journal:  Hypertension       Date:  2008-06       Impact factor: 10.190

Review 4.  Progress and challenges in anti-obesity pharmacotherapy.

Authors:  Daniel H Bessesen; Luc F Van Gaal
Journal:  Lancet Diabetes Endocrinol       Date:  2017-09-14       Impact factor: 32.069

5.  Five-year effectiveness of bariatric surgery on disease remission, weight loss, and changes of metabolic parameters in obese patients with type 2 diabetes: A population-based propensity score-matched cohort study.

Authors:  Tingting Wu; Simon Kin Hung Wong; Betty Tsz Ting Law; Eleanor Grieve; Olivia Wu; Daniel King Hung Tong; David Kai Wing Leung; Cindy Lo Kuen Lam; Carlos King Ho Wong
Journal:  Diabetes Metab Res Rev       Date:  2020-01-07       Impact factor: 4.876

6.  Improvement in coronary circulatory function in morbidly obese individuals after gastric bypass-induced weight loss: relation to alterations in endocannabinoids and adipocytokines.

Authors:  Alessandra Quercioli; Fabrizio Montecucco; Zoltan Pataky; Aurelien Thomas; Giuseppe Ambrosio; Christian Staub; Vincenzo Di Marzo; Osman Ratib; Francois Mach; Alain Golay; Thomas H Schindler
Journal:  Eur Heart J       Date:  2013-03-13       Impact factor: 29.983

7.  2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Donna K Arnett; Roger S Blumenthal; Michelle A Albert; Andrew B Buroker; Zachary D Goldberger; Ellen J Hahn; Cheryl Dennison Himmelfarb; Amit Khera; Donald Lloyd-Jones; J William McEvoy; Erin D Michos; Michael D Miedema; Daniel Muñoz; Sidney C Smith; Salim S Virani; Kim A Williams; Joseph Yeboah; Boback Ziaeian
Journal:  J Am Coll Cardiol       Date:  2019-03-17       Impact factor: 24.094

8.  Obesity-associated hyperleptinemia alters the gliovascular interface of the hypothalamus to promote hypertension.

Authors:  Tim Gruber; Chenchen Pan; Raian E Contreras; Tobias Wiedemann; Donald A Morgan; Alicja A Skowronski; Sandrine Lefort; Cahuê De Bernardis Murat; Ophelia Le Thuc; Beata Legutko; Francisco J Ruiz-Ojeda; María de la Fuente-Fernández; Angel Luis García-Villalón; Daniel González-Hedström; Melanie Huber; Klara Szigeti-Buck; Timo D Müller; Siegfried Ussar; Paul Pfluger; Steve C Woods; Ali Ertürk; Charles A LeDuc; Kamal Rahmouni; Miriam Granado; Tamas L Horvath; Matthias H Tschöp; Cristina García-Cáceres
Journal:  Cell Metab       Date:  2021-05-04       Impact factor: 27.287

Review 9.  Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials.

Authors:  Viktoria L Gloy; Matthias Briel; Deepak L Bhatt; Sangeeta R Kashyap; Philip R Schauer; Geltrude Mingrone; Heiner C Bucher; Alain J Nordmann
Journal:  BMJ       Date:  2013-10-22

10.  Body-mass index, blood pressure, and cause-specific mortality in India: a prospective cohort study of 500 810 adults.

Authors:  Vendhan Gajalakshmi; Ben Lacey; Vendhan Kanimozhi; Paul Sherliker; Richard Peto; Sarah Lewington
Journal:  Lancet Glob Health       Date:  2018-07       Impact factor: 38.927

View more
  1 in total

Review 1.  Interplay between baroreflex sensitivity, obesity and related cardiometabolic risk factors (Review).

Authors:  Sofia K Konstantinidou; Georgia Argyrakopoulou; Nicholas Tentolouris; Vangelis Karalis; Alexander Kokkinos
Journal:  Exp Ther Med       Date:  2021-11-23       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.